Kashiv BioSciences Appoints Dr. Sandeep Athalye as Global CEO
Slice of Healthcare Team
11/05/2024
Key Highlights
- Dr. Sandeep Athalye appointed as Global CEO of Kashiv BioSciences.
- Over 20 years of experience in top pharmaceutical firms.
- Will drive strategic growth across U.S., Europe, and Asia.
- Known for patient-centric and innovative strategies.
- Focused on expanding biosimilars pipeline and global reach.
Source: Business Wire
Notable Quotes
“ We are delighted to welcome Dr. Athalye to Kashiv. His appointment comes at a pivotal time as we accelerate our growth in the rapidly expanding biosimilars sector. We are confident that Dr. Athalye’s industry expertise and leadership will be instrumental in achieving Kashiv’s ambitious global vision. ”
Chirag and Chintu Patel, Co-Founders and Board Members at Kashiv BioSciences, LLC
“ Kashiv is an ambitious biosimilars company founded with a vision to bring affordable and accessible biosimilars globally. I am very excited for the opportunity to use technology and innovation to drive Kashiv to become one of the leading developers of medicines in the biologics space. ”
Dr. Sandeep Nilkanth Athalye, Global CEO at Kashiv BioSciences, LLC
